EDITORIAL SECTIONS

Joseph Xavier is currently pursuing his PhD in the Division of Toxicology,SCTIMST, Trivandrum, Kerala. He is currently working on the development of multi-organ-on-a-chip for disease modelling and toxicity assessments. His work also focuses on elucidating the cellular mechanism of toxicity of nanomaterials.

Akhil Venugopal is currently working as a Junior Research Fellow in the Division of Toxicology, SCTIMST, Trivandrum. He obtained his Integrated BS-MS in Chemistry from Indian Institute of Science Education and Research (IISER), Mohali. His research work is focused on the fabrication of multi-organ micro physiological devices for pre-clinical studies.

Arathi Ashok obtained her Masters in Microbiology from Amrita Vishwa Vidyapeetham, Kerala. She is currently working as a Junior Research Fellow in the Division of Toxicology, SCTIMST, Trivandrum. Her research work lies in the development of organ-on-a chip devices for toxicity assessment.

PV. Mohanan, FNASc, FRSB, Scientist-G and Head of Division of Toxicology and Associate Dean (PhD program) in Sree Chitra Tirunal Institute for Medical Sciences and Technology (SCTIMST), Govt. of India. He has more than 33 years of research experience in Toxicology. He is a Certified Biological Safety Specialist and has authored 233 publications and edited 6 books. He is also a Visiting Professor and Visiting Researcher at Toyo University, Japan.

Apoorva More works as Assistant Professor in Pharmaceutical Chemistry department at St. John Institute of Pharmacy and Research, Palghar. She has completed her M. Pharm in Quality Assurance. Her research interests are Lipid based technologies, formulation development, nutraceuticals and novel drug delivery systems.

Bharat Dhokchawale is currently working at St. John Institute of Pharmacy and Research as Associate Professor and Head of Pharmaceutical Chemistry department. He holds Ph. D. in Pharmaceutical Sciences. His research interest includes Prodrug synthesis, synthetic chemistry and solubility enhancement of poorly water soluble drugs. He has total 14 years of teaching experience and 19 publications to his credit in International and National journals of repute. He has presented several papers in international conferences.

Dr. Marco Pirisinu graduated from the University of Sassari, Italy, with a degree in Biomedical Sciences focusing on the novel design and application of cell penetrating peptide targeting mitochondria. He has more than 10 years of research experience working with academic institutions and biotechnology companies. His primary research interest are nanomedicine, targeted therapy and drug delivery systems. Dr. Pirisinu is first author and corresponding author of peer reviewed articles and Guest Editor forSCI-indexed journals. He is currently Senior Scientist at City University of Hong Kong and Head of Innovative Product Development at Jotbody (HK) Limited.

Dr. Likun Wei obtained his BEng from Tianjin University of Technology, majoring in computer science and MSA from Shanghai Ocean University, majoring in agriculture.He completed his PhD in Biomedical Sciences at City University of Hong Kong in 2021. His PhD work demonstrated a small shark model for affordable high affinity sdAb production.He has co-authored 12 publications in SCI-indexed journals including Nature Communications, Bioresource Technology, Journal of Extracellular Vesicles, Iscience, The Journal of Immunology, and Frontiers in Bioengineering and Biotechnology.  Dr. Likun Wei is currently R&D Lead at Jotbody (HK) Limited.

With over 15 years of experience, Aarti brings deep expertise across pharmaceutical contract research services and technology‑enabled drug discovery and development. She leads the Contract Research Services program, covering peripheral and ancillary service segments such as tech vendors, eClinical solution providers, central labs, and related ecosystems. Her strengths span market intelligence, forecasting, competitive benchmarking, and strategic opportunity assessment as well as growth advisory services, that consistently support executive decision‑making for global clients. She is  regarded as a trusted growth expert, and is adept in supporting stakeholders navigate industry disruption, accelerate innovation, and seize transformative opportunities across the rapidly evolving Contract Services Landscape.

Natalja Genina, Associate professor at University of Copenhagen (UCPH), Denmark. Her research interest include fabrication of advanced drug delivery systems and their integration into digital health. Dr. Genina has a remarkable publication record in her research field.

Professor, UCPH

Associate Professor, UCPH

Sofia Kälvemark Sporrong, Professor at Uppsala University, Sweden. Expert in social pharmacy. Kälvemark Sporrong is a social scientist doing research within the area of pharmaceuticals. Her research interests include the patient perspective on drug use, pharmaceutical policy and professional ethics for health care staff.